Sulforaphane has opposing effects on TNF-alpha stimulated and unstimulated synoviocytes

Arthritis Research and Therapy

Volumn 14, Issue 5, 2012, Pages

  Fragoulis, Athanassios ^a   Laufs, Jendrik ^a   Müller, Susanna ^a   Soppa, Ulf ^a   Siegl, Stephanie ^a   Reiss, Lucy K ^a   Tohidnezhad, Mersedeh ^a   Rosen, Christian ^a   Tenbrock, Klaus ^a   Varoga, Deike ^b   Lippross, Sebastian ^b   Pufe, Thomas ^a   Wruck, Christoph J ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUCIFERASE; STROMELYSIN; SULFORAPHANE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; CASPASE; CYTOKINE; ISOTHIOCYANIC ACID DERIVATIVE; NFE2L2 PROTEIN, HUMAN; SULFORAFAN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARTILAGE DEGENERATION; CASE REPORT; CELL PROLIFERATION; CELL PROTECTION; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OXIDATIVE STRESS; PROTEIN EXPRESSION; REPORTER GENE; SYNOVIOCYTE; ZYMOGRAPHY; AGONISTS; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL LINE; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; SYNOVIUM;

APOPTOSIS; CASPASES; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOTHIOCYANATES; NF-E2-RELATED FACTOR 2; NF-KAPPA B; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867409491     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4059     Document Type: Article

References (30)

1. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7:429-442. 10.1038/nri2094, 17525752.
2. Roman-Blas JA, Jimenez SA. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr Cartil 2006, 14:839-848. 10.1016/j.joca.2006.04.008, 16730463.
3. Grimbacher B, Aicher WK, Peter HH, Eibel H. TNF-alpha induces the transcription factor Egr-1, pro-inflammatory cytokines and cell proliferation in human skin fibroblasts and synovial lining cells. Rheumatol Int 1998, 17:185-192. 10.1007/s002960050032, 9542779.
4. Abeles AM, Pillinger MH. The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases. Bull NYU Hosp Jt Dis 2006, 64:20-24.
5. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 2002, 99:11908-11913. 10.1073/pnas.172398899, 129367, 12193649.
6. Myzak MC, Dashwood RH. Chemoprotection by sulforaphane: keep one eye beyond Keap1. Cancer Lett 2006, 233:208-218. 10.1016/j.canlet.2005.02.033, 2276573, 16520150.
7. Fay J, Varoga D, Wruck CJ, Kurz B, Goldring MB, Pufe T. Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants. Arthritis Res Ther 2006, 8:R189. 10.1186/ar2102, 1794535, 17187682.
8. Wruck CJ, Fragoulis A, Gurzynski A, Brandenburg LO, Kan YW, Chan K, Hassenpflug J, Freitag-Wolf S, Varoga D, Lippross S, Pufe T. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis 2011, 70:844-850. 10.1136/ard.2010.132720, 21173018.
9. Hinoi E, Takarada T, Fujimori S, Wang L, Iemata M, Uno K, Yoneda. Nuclear factor E2 p45-related factor 2 negatively regulates chondrogenesis. Bone 2007, 40:337-344. 10.1016/j.bone.2006.08.016, 17029980.
10. Aicher WK, Dinkel A, Grimbacher B, Haas C, Seydlitz-Kurzbach EV, Peter HH, Eibel H. Serum response elements activate and cAMP responsive elements inhibit expression of transcription factor Egr-1 in synovial fibroblasts of rheumatoid arthritis patients. Int Immunol 1999, 11:47-61. 10.1093/intimm/11.1.47, 10050673.
11. Haas C, Aicher WK, Dinkel A, Peter HH, Eibel H. Characterization of SV40T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-1, HLA-DR and some surface receptors. Rheumatol Int 1997, 16:241-247. 10.1007/BF01375656, 9106935.
12. Hess S, Rheinheimer C, Tidow F, Bartling G, Kaps C, Lauber J, Buer J, Klos A. The reprogrammed host: Chlamydia trachomatis-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptotic genes. Arthritis Rheum 2001, 44:2392-2401. 10.1002/1529-0131(200110)44:10<2392::AID-ART404>3.0.CO;2-I, 11665982.
13. Häupl T, Yahyawi M, Lübke C, Ringe J, Rohrlach T, Burmester GR, Sittinger M, Kaps C. Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen 2007, 12:328-340. 10.1177/1087057107299261, 17379860.
14. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991, 266:11632-9.
15. Wruck CJ, Claussen M, Fuhrmann G, Romer L, Schulz A, Pufe T, Waetzig V, Peipp M, Herdegen T, Gotz ME. Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. J Neural Transm Suppl 2007, 72:57-67. 10.1007/978-3-211-73574-9_9, 17982879.
16. Matsubara M, Girard MT, Kublin CL, Cintron C, Fini ME. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol 1991, 147:425-439. 10.1016/0012-1606(91)90300-R, 1655541.
17. Li X, Makarov SS. An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes. Proc Natl Acad Sci USA 2006, 103:17432-17437. 10.1073/pnas.0607939103, 1859946, 17088540.
18. Karouzakis E, Neidhart M, Gay RE, Gay S. Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 2006, 106:8-13. 10.1016/j.imlet.2006.04.011, 16824621.
19. Kong JS, Yoo SA, Kim HS, Kim HA, Yea K, Ryu SH, Chung YJ, Cho CS, Kim WU. Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate. Arthritis Rheum 2010, 62:159-170. 10.1002/art.25017, 20039434.
20. Brandenburg LO, Kipp M, Lucius R, Pufe T, Wruck CJ. Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm Res 2010, 59:443-450. 10.1007/s00011-009-0116-5, 19924513.
21. McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, Wolf CR, Cavin C, Hayes JD. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 2001, 61:3299-3307.
22. Wruck CJ, Streetz K, Pavic G, Gotz ME, Tohidnezhad M, Brandenburg LO, Varoga D, Eickelberg O, Herdegen T, Trautwein C, Cha K, Kan YW, Pufe T. Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter. J Biol Chem 2011, 286:4493-4499. 10.1074/jbc.M110.162008, 3039356, 21127061.
23. Rannou F, Francois M, Corvol MT, Berenbaum F. Cartilage breakdown in rheumatoid arthritis. Joint Bone Spine 2006, 73:29-36. 10.1016/j.jbspin.2004.12.013, 16087381.
24. Legendre F, Bogdanowicz P, Martin G, Domagala F, Leclercq S, Pujol JP, Ficheux H. Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways. Clin Exp Rheumatol 2007, 25:546-555.
25. d'Abusco AS, Calamia V, Cicione C, Grigolo B, Politi L, Scandurra R. Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes. Arthritis Res Ther 2007, 9:R104. 10.1186/ar2307, 2212570, 17925024.
26. Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, Makarov SS. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 1998, 95:13859-13864. 10.1073/pnas.95.23.13859, 24931, 9811891.
27. Aikawa Y, Morimoto K, Yamamoto T, Chaki H, Hashiramoto A, Narita H, Hirono S, Shiozawa S. Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat Biotechnol 2008, 26:817-823. 10.1038/nbt1412, 18587386.
28. Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009, 47:1304-1309. 10.1016/j.freeradbiomed.2009.07.035, 2763938, 19666107.
29. Piantadosi CA, Withers CM, Bartz RR, MacGarvey NC, Fu P, Sweeney TE, Welty-Wolf KE, Suliman HB. Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression. J Biol Chem 2011, 286:16374-16385. 10.1074/jbc.M110.207738, 3091243, 21454555.
30. Wei Y, Chen P, de Bruyn M, Zhang W, Bremer E, Helfrich W. Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol 2010, 10:42. 10.1186/1471-230X-10-42, 2873601, 20444253.